Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « factors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
factorial < factors < fail  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 92.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000103 (2016) Gustaf Lindgren [Suède] ; Elisabeth Kjellén [Suède] ; Johan Wennerberg [Suède] ; Lars Ekblad [Suède]Wound‐healing factors can prime head and neck cancer cells to increase their tumor‐forming capacity
000154 (2011) Atsushi Kaneko [Japon] ; Daihei Kida [Japon] ; Kiwamu Saito [Japon] ; Masami Tsukamoto [Japon] ; Tomotaro Sato [Japon]Clinical results for tocilizumab over one year in the clinical setting as assessed by CDAI (clinical disease activity index): CRP at week 12 and MMP-3 at week 24 are predictive factors for CDAI
000155 (2009) Misato Hashizume [Japon] ; Naohiko Hayakawa [Japon] ; Miho Suzuki [Japon] ; Masahiko Mihara [Japon]IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system
000173 (2013) Nam Trung Nguyen [Japon, Viêt Nam] ; Taisuke Nakahama [Japon] ; Tadamitsu Kishimoto [Japon]Aryl hydrocarbon receptor and experimental autoimmune arthritis
000174 (2012) M. Gaubitz [Allemagne]Biologika 2012
000178 (2010) G. Dückers [Allemagne] ; T. Niehues [Allemagne]Die Bedeutung von Biologika bei der Therapie der SoJIA (Morbus Still)
000188 (2016) Andreas Bayer [Allemagne] ; Justus Lammel [Allemagne] ; Franziska Rademacher [Allemagne] ; Justus Gro [Allemagne] ; Markus Siggelkow [Allemagne] ; Sebastian Lippross [Allemagne] ; Tim Klüter [Allemagne] ; Deike Varoga [Allemagne] ; Mersedeh Tohidnezhad [Allemagne] ; Thomas Pufe [Allemagne] ; Jochen Cremer [Allemagne] ; Regine Gl Ser [Allemagne] ; Jürgen Harder [Allemagne]Platelet‐released growth factors induce the antimicrobial peptide human beta‐defensin‐2 in primary keratinocytes
000204 (2010) C. J. Edwards [Royaume-Uni] ; E. Williams [Royaume-Uni]The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis
000238 (2012) H. G. Nü Lein [Allemagne]Wie früh würden wir Biologika wirklich einsetzen?
000278 (2013) Frédéric Perros [France] ; Marc Humbert [France] ; Sylvia Cohen-Kaminsky [France]Hypertension artérielle pulmonaire
000303 (2013) Verena Wieser [Autriche] ; Alexander R. Moschen [Autriche] ; Herbert Tilg [Autriche]Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective
000304 (2013) Tomokazu Nagao ; Reina Kusunoki ; Chiaki Iwamura ; Shigeto Kobayashi ; Wako Yumura ; Yosuke Kameoka [Japon] ; Toshinori Nakayama ; Kazuo Suzuki [Japon]Correlation of interleukin‐6 and monocyte chemotactic protein‐1 concentrations with crescent formation and myeloperoxidase‐specific anti‐neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti‐interleukin‐6 receptor antibody or mizoribine
000308 (2013) M. Vis [Pays-Bas] ; M. Güler-Yüksel [Pays-Bas] ; W. F. Lems [Pays-Bas]Can bone loss in rheumatoid arthritis be prevented?
000507 (2013) Todd A. Morrison [États-Unis] ; Mark Figgie [États-Unis] ; Andy O. Miller [États-Unis] ; Susan M. Goodman [États-Unis]Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: a Review of Risk Factors and Current Approaches to Diagnosis and Management
000510 (2013) H. Pieringer [Autriche] ; U. C. Hoppe [Autriche]Warum die rheumatoide Arthritis den Kardiologen braucht
000511 (2011) Stefan Kleinert [Allemagne] ; Hans-Peter Tony [Allemagne] ; Andreas Krause [Allemagne] ; Martin Feuchtenberger [Allemagne] ; Siegfried Wassenberg [Allemagne] ; Constanze Richter [Allemagne] ; Ekkehard Röther [Allemagne] ; Wolfgang Spieler [Allemagne] ; Holger Gnann [Allemagne] ; Bianca M. Wittig [Allemagne]Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study
000520 (2013) C. Carnovale [Italie] ; V. Perrone [Italie] ; C. Borsadoli [Italie] ; A. Mambrini [Italie] ; A. Speziali [Italie] ; G. Froldi [Italie] ; S. Antoniazzi [Italie] ; L. Magistro [Italie] ; E. Clementi [Italie] ; S. Radice [Italie]A case of urinary incontinence by hydroxychloroquine in a geriatric patient
000529 (2013) J.-E. Gottenberg [France] ; C. Mpofu [Suisse] ; W. Bensen [Canada] ; A. Rubbert-Roth [Allemagne] ; F. Irazoque [Mexique] ; V. Martínez Taboada [Espagne] ; C. Chung [États-Unis] ; L. Hinsch-Gylvin [Suisse] ; C. Ferri [Italie] ; P. Emery [Royaume-Uni]AB0541 Factors associated with selection of rituximab vs alternative TNF inhibitor (TNFI) following TNFI failure in patients with rheumatoid arthritis: Sub-analysis of switch-RA, a global, comparative effectiveness observational study
000536 (2009) Katalin Eder [Hongrie] ; Noemi Baffy [Hongrie] ; Andras Falus [Hongrie] ; Andras K. Fulop [Hongrie]The major inflammatory mediator interleukin-6 and obesity
000568 (2014) Koji Chiba [Japon] ; Hiroyuki Yoshitsugu [États-Unis] ; Yuto Kyosaka [Japon] ; Satofumi Iida [Japon] ; Koichiro Yoneyama [Japon] ; Takahiko Tanigawa [Allemagne] ; Takashi Fukushima [Japon] ; Masaki Hiraoka [Japon]A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: Are Japanese phase I studies still needed?
000575 (2014) Chi Chiu Mok [République populaire de Chine] ; Ka Yan Chan [République populaire de Chine] ; Ka Lai Lee [République populaire de Chine] ; Lai Shan Tam [République populaire de Chine] ; Ka Wing Lee [République populaire de Chine]Factors associated with withdrawal of the anti‐TNFα biologics in the treatment of rheumatic diseases: data from the Hong Kong Biologics Registry

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "factors" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "factors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    factors
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021